To Get More Information on MRI-guided Neurosurgical Ablation Market - Request Sample Report
The MRI-guided Neurosurgical Ablation Market size was valued at USD 412.08 million in 2023 and is expected to reach USD 654.69 billion by 2032, growing at a CAGR of 5.28% over the forecast period of 2024-2032.
The MRI-guided neurosurgical ablation market is growing rapidly owing to the increased demand for minimally invasive treatments, innovation in imaging technologies, and higher incidence of neurological disorders. MRI-guided systems provide excellent precision in targeting lesions within the brain that are deep in the brain and can be best used in treating conditions such as brain tumors, epilepsy, and Parkinson's disease. These technologies, like Medtronic's Visualase MRI-guided Laser Ablation System and Monteris Medical's NeuroBlate System, will revolutionize neurosurgical procedures by reducing the need for open surgery, leading to faster recovery times, less risk of infection, and improved outcomes for patients.
Technological innovations, including the integration of real-time imaging with laser ablation or focused ultrasound, are significantly enhancing the efficacy and accuracy of these systems. Companies like Insightec and Brainlab AG have introduced products that leverage MRI imaging for precise treatment of neurological conditions, contributing to their increasing adoption. In addition, the growing trend of outpatient procedures, driven by both technological advancements and healthcare cost considerations, is further accelerating market growth.
The rising incidence of neurological diseases, including epilepsy, brain tumors, and Parkinson's disease, is also driving demand for advanced neurosurgical treatments. According to the Global Burden of Disease (GBD) study, the burden of neurological conditions will nearly double by 2050. In addition, the aging population in developed regions worldwide will contribute to the market's growth because elderly people are more susceptible to neurological conditions. Moreover, research and clinical trials to expand the use of MRI-guided ablation techniques are opening new avenues for treating previously inoperable conditions.
Drivers
Technological Advancement in MRI-guided Neurosurgical Ablation
More advanced MRI-guided neurosurgical ablation systems will drive the growth of the market. Improvements in MRI technology are enhancing the resolution of imaging and precision, thus making these procedures more effective and less invasive. For example, technologies such as Insightec's Exablate Prime and Monteris Medical's NeuroBlate with the NB3 FullFire 1.6mm laser probe are enhancing the accuracy and flexibility of treatments for neurological conditions such as epilepsy and brain tumors. These developments help in achieving improved patient results, shorter recovery periods, and fewer complications, which are essential factors in encouraging the use of MRI-guided neurosurgical ablation.
Rising Incidence of Neurological Disorders and the Need for Minimally Invasive Procedures
The increasing incidence rate of neurological disorders, such as epilepsy glioblastoma, and other brain tumors, is fuelling the need for effective treatments like MRI-guided neurosurgical ablation. According to the Global Burden of Disease (GBD) study, more than 40% of the global population has a neurological condition. This is equivalent to 3.4 billion people. According to a report from the World Health Organization, over 50 million people across the world are affected with epilepsy. In response to this, many providers are moving towards minimally invasive treatments that offer high accuracy and reduce risks associated with an open surgical procedure.
For instance, treatments of epilepsy, which make up over 50% of MRI-guided ablation procedures, take advantage of the high precision of MRI systems to target specific areas of the brain, causing minimal damage to healthy tissue. Moreover, with the increased coverage of insurance policies for these procedures, access to them is further being promoted.
Restraint
High Cost and Limited Access to MRI-guided Neurosurgical Ablation Systems
The cost-intensive nature of the technology is one significant restraint to the growth of the MRI-guided neurosurgical ablation market. Advanced MRI systems and related neurosurgical ablation equipment usually require huge investments, thus making it difficult for healthcare providers in low-resource settings to adopt such solutions. For example, the cost of an MRI-guided neurosurgical ablation system may be more than several million dollars, excluding the running operational and maintenance costs. Another complexity is the availability of skilled specialists to operate these systems. This high-cost limits access to these treatments in developing regions, where alternative, more cost-effective options are preferred.
A 2023 study revealed that 46% of the hospitals in low-income countries find it difficult to access MRI technology for neurosurgery. Meanwhile, only 10% of the hospitals can afford such an advanced MRI-guided neurosurgical system.
By Product
In 2023, the Accessories segment accounted for the largest share of 35% and is expected to witness the highest growth between 2024 and 2032. This growth is mainly due to the increased usage of accessories during neurosurgical procedures. Essential tools such as curettes, rongeurs, and dissectors are important for delicate surgeries like minimally invasive discectomies or opening skull bone windows. The accessories are designed to help neurosurgeons diagnose and restore the central nervous system with accuracy and safety.
The demand for quality functional accessories is on an upward rise as they become critical elements in achieving successful outcomes from neurosurgery. These would enhance maneuverability, precision, and the general functionality of neurosurgery, contributing directly to the expected increase in the MRI-guided neurosurgical ablation market in the following years.
By End Use
In 2023, Hospitals dominated the market with a market share of 63%. This dominance is attributed to the fact that hospitals typically house specialized neurosurgery departments equipped with advanced technology and staffed by highly skilled professionals. Due to their better ability to offer complete care and treatment, hospitals are usually the best locations for complex neurosurgeries like MRI-guided laser ablation for treating brain tumors or epilepsy. Therefore, during the forecasted period, demand for the use of MRI-guided neurosurgical ablation devices within hospitals will keep rising.
The Ambulatory Surgical Center (ASC) segment is expected to grow at the highest compound annual growth rate of 9% from 2024 to 2032. ASCs offer same-day surgeries and typically perform less invasive procedures, which lead to fewer complications and faster recovery times than traditional surgeries. ASCs are increasingly using MRI-guided neurosurgical ablation technologies for brain tumor treatments, where laser ablation surgeries require less invasive approaches and shorter recovery periods. Therefore, this segment is expected to grow the fastest because it can provide efficient, minimally invasive procedures with fewer complications.
Do You Need any Customization Research on MRI-guided Neurosurgical Ablation Market - Inquire Now
In 2023, North America dominated the market with the largest share of MRI-guided neurosurgical ablation market, at 40%. This is primarily attributed to the region's already established healthcare infrastructure, the growth in the incidence of brain cancers and malignant tumors, and the availability of highly trained neurosurgeons. The increasing incidence of targeted diseases such as neurodegenerative disorders and brain tumors mainly fuels the growth in the MRI-guided neurosurgical ablation market. Major industry players like Medtronic, Boston Scientific Corporation, and Insightec Ltd. also strengthen the region's market. The number of minimally invasive neurosurgical procedures is on the rise, and neurological diseases are on the rise; hence, it fuels the market growth in North America.
The Asia Pacific region is expected to grow the fastest with a compound annual growth rate (CAGR) of 8% from 2024 to 2032. Contributing factors to this growth include a large patient population, increasing medical tourism, rising government healthcare spending, and a growing trend toward minimally invasive surgeries. In addition, the growth of intensive care units in hospitals and ambulatory surgical centers for the treatment of brain cancer, Alzheimer's disease, and other neurological disorders is driving the growth of the market in this region.
Medtronic (Visualase MRI-guided Laser Ablation System, O-arm Surgical Imaging System)
Monteris Medical (NeuroBlate System, AtamA Stabilization System)
Brainlab AG (Curve Image-Guided Surgery, Elements Laser Navigation Software)
Insightec (Exablate Neuro, Exablate 4000 Series)
Boston Scientific Corporation (Vercise Deep Brain Stimulation Systems, iLab Ultrasound Imaging System)
Elekta AB (Leksell Gamma Knife Icon, Elekta Neuromag)
Zimmer Biomet (ROSA ONE Brain, ROSA Planning Software)
Stryker Corporation (Stryker NAV3i Image-Guided System, Airo TruCT Mobile Imaging System)
Philips Healthcare (Ingenia Ambition 1.5T MRI, SmartPath to dStream MRI Upgrades)
Siemens Healthineers (MAGNETOM Vida 3T MRI, syngo.via Neurosuite)
GE HealthCare (SIGNA Architect MRI System, Omni Legend PET/CT System)
Synaptive Medical (Modus V Digital Microscope, BrightMatter Guide)
Varian Medical Systems (Edge Radiosurgery System, TrueBeam Radiotherapy System)
MedActa International (MySolutions Personal Alignment Technology, GMK Sphere for Neurological Applications)
KARL STORZ GmbH & Co. KG (Image1 S 4K Rubina System, NAV1 ENT Surgical Navigation)
Hitachi Medical Systems (Echelon Oval 1.5T MRI, Oasis High-Field Open MRI)
Inomed Medizintechnik GmbH (C2 Nerve Monitor, NeuroExplorer Navigation System)
Hyperfine (Swoop Portable MRI System, Neurovascular Imaging Software)
ClearPoint Neuro, Inc. (ClearPoint Neuro Navigation System, SmartFrame Stereotactic Frame)
Integra LifeSciences Corporation (Camino ICP Monitor, DuraGen Dural Graft Matrix)
May 2024, Monteris Medical- NeuroBlate NB3 FullFire 1.6mm Laser Probe- Monteris released the smallest commercially available laser probe for brain surgery, known as NeuroBlate NB3 FullFire 1.6mm. The latest product approved by the FDA in December 2023 allows precision in treating almost all brain lesions, be it a tumor or a focus for epilepsy. The more advanced cooling and laser technology enhance the precision and flexibility of laser ablation procedures for adult and pediatric patients. It promises to simplify the surgical process with a smaller device that minimizes the use of multiple tools.
In February 2024, Anthem Blue Cross and Blue Shield (BCBS) introduced insurance coverage for the innovative focused ultrasound pallidotomy procedure. This decision is part of their broader efforts to enhance Parkinson’s disease treatment options under their comprehensive coverage plan.
In 2024, with New Innovations in MRI-Guided Focused Ultrasound, Medtronic has been working on its MRI-guided Focused Ultrasound (MRgFUS) technology for neurosurgical ablation. Its advanced system will be even more precise and effective for the treatment of Parkinson's disease and essential tremor, using non-invasive surgery with the help of MRI guidance for enhanced treatment success.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 412.08 million |
| Market Size by 2032 | US$ 654.69 million |
| CAGR | CAGR of 5.28% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (MRI-guided RF Ablation Systems, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, Accessories) •By End-use (Hospitals, Clinics, Ambulatory Surgical Centers) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Medtronic, Monteris Medical, Brainlab AG, Insightec, Boston Scientific Corporation, Elekta AB, Zimmer Biomet, Stryker Corporation, Philips Healthcare, Siemens Healthineers, GE HealthCare, Synaptive Medical, Varian Medical Systems, MedActa International, KARL STORZ GmbH & Co. KG, Hitachi Medical Systems, Inomed Medizintechnik GmbH, Hyperfine, ClearPoint Neuro, Inc., Integra LifeSciences Corporation. |
| Key Drivers | •Technological Advancement in MRI-guided Neurosurgical Ablation •Rising Incidence of Neurological Disorders and the Need for Minimally Invasive Procedures |
| Restraints | •High Cost and Limited Access to MRI-guided Neurosurgical Ablation Systems |
Ans- The MRI-guided Neurosurgical Ablation Market was valued at USD 412.08 million in 2023 and is expected to reach USD 654.69 million by 2032.
Ans – The CAGR rate of the MRI-guided Neurosurgical Ablation Market during 2024-2032 is 5.28%.
Ans- The Accessories denature segment dominated MRI-guided Neurosurgical Ablation market by 35%
Ans- North America held the largest revenue share by 40% of MRI-guided Neurosurgical Ablation Market.
Ans- Asia Pacific is the fastest-growing region in the MRI-guided Neurosurgical Ablation Market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. MRI-guided Neurosurgical Ablation Market Segmentation, by Product
7.1 Chapter Overview
7.2 MRI-guided RF ablation systems
7.2.1 MRI-guided RF ablation systems Market Trends Analysis (2020-2032)
7.2.2 MRI-guided RF ablation systems Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 MRI-guided laser ablation systems
7.3.1 MRI-guided laser ablation systems Market Trends Analysis (2020-2032)
7.3.2 MRI-guided laser ablation systems Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 MRI-guided focused ultrasound systems
7.4.1 MRI-guided focused ultrasound systems Market Trends Analysis (2020-2032)
7.4.2 MRI-guided focused ultrasound systems Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Accessories
7.5.1 Accessories Market Trends Analysis (2020-2032)
7.5.2 Accessories Market Size Estimates and Forecasts to 2032 (USD Million)
8. MRI-guided Neurosurgical Ablation Market Segmentation, by End User
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Clinics
8.3.1 Clinics Market Trends Analysis (2020-2032)
8.3.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Ambulatory Surgical Centers
8.4.1 Ambulatory Surgical Centers Market Trends Analysis (2020-2032)
8.4.2 Ambulatory Surgical Centers Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.2.3 North America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.4 North America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.5.2 USA MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.6.2 Canada MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.7.2 Mexico MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.1.3 Eastern Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.4 Eastern Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.1.5 Poland
9.3.1.5.1 Poland MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.5.2 Poland MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.1.6 Romania
9.3.1.6.1 Romania MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.6.2 Romania MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.1.7 Hungary
9.3.1.7.1 Hungary MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.7.2 Hungary MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.1.8 Turkey
9.3.1.8.1 Turkey MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.8.2 Turkey MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.9.2 Rest of Eastern Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.2.3 Western Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.4 Western Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.5 Germany
9.3.2.5.1 Germany MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.5.2 Germany MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.6 France
9.3.2.6.1 France MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.6.2 France MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.7 UK
9.3.2.7.1 UK MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.7.2 UK MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.8 Italy
9.3.2.8.1 Italy MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.8.2 Italy MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.9 Spain
9.3.2.9.1 Spain MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.9.2 Spain MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.10.2 Netherlands MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.11.2 Switzerland MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.12 Austria
9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.12.2 Austria MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.13.2 Rest of Western Europe MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.4.3 Asia Pacific MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.4 Asia Pacific MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.5 China
9.4.5.1 China MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 China MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.6 India
9.4.5.1 India MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 India MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 Japan MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.6.2 South Korea MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.7 Vietnam
9.4.7.1 Vietnam MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.8 Singapore
9.4.8.1 Singapore MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.8.2 Singapore MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.9 Australia
9.4.9.1 Australia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.9.2 Australia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.10.2 Rest of Asia Pacific MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.1.3 Middle East MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.4 Middle East MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.1.5 UAE
9.5.1.5.1 UAE MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.5.2 UAE MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.1.6 Egypt
9.5.1.6.1 Egypt MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.6.2 Egypt MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.7.2 Saudi Arabia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.1.8 Qatar
9.5.1.8.1 Qatar MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.8.2 Qatar MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.9.2 Rest of Middle East MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.2.3 Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.4 Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.2.5 South Africa
9.5.2.5.1 South Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.5.2 South Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.6.2 Nigeria MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.7.2 Rest of Africa MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.6.3 Latin America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.4 Latin America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.5.2 Brazil MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.6.2 Argentina MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.6.7 Colombia
9.6.7.1 Colombia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.7.2 Colombia MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.8.2 Rest of Latin America MRI-guided Neurosurgical Ablation Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)
10. Company Profiles
10.1 Medtronic
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Monteris Medical
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Brainlab AG
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Zimmer Biomet
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Philips Healthcare
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Siemens Healthineers
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Synaptive Medical
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Varian Medical Systems
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 MedActa International
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
MRI-guided Neurosurgical Ablation by Product
MRI-guided RF ablation systems
MRI-guided laser ablation systems
MRI-guided focused ultrasound systems
Accessories
MRI-guided Neurosurgical Ablation by End-use
Hospitals
Clinics
Ambulatory Surgical Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Cryoablation Devices Market size will reach $1295.34 Mn by 2032, was valued at $489.53 Mn in 2023 & growing at a CAGR of 10.26% over 2024-2032.
The Process Analytical Technology Market Size was valued at USD 3.50 Billion in 2023, and is expected to reach USD 10.19 Billion by 2032, and grow at a CAGR of 13.29%.
The Healthcare Information Technology Market Size was valued at USD 229.43 billion in 2023, and is expected to reach USD 1827.12 billion by 2031 and grow at a CAGR of 29.61% over the forecast period 2024-2031.
The Non-Invasive Prenatal Testing (NIPT) Market is expected to reach USD 17.75 Bn by 2031 and was valued at USD 6.4 Bn in 2023, and grow at a CAGR of 13.6% over the forecast period of 2024-2031.
The Personalized Medicine Market was valued at USD 530.01 billion in 2023, and is expected to reach USD 1,078.17 billion by 2032, and grow at a CAGR of 8.21% over the forecast period 2024-2032.
The Medical Supplies and Labware Market size is valued at USD 143.48 Billion in 2023 & it is estimated to reach USD 291.68 Billion by 2032, growing at a CAGR of 8.23% during 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
